Ryvu Therapeutics S.A. announced that it has received 22 million in a round of funding from new investor, European Fund for Strategic Investments, a fund managed by European Investment Bank, Investment Arm on August 17, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.8 PLN | +1.45% | +10.06% | -2.96% |
May. 17 | Transcript : Ryvu Therapeutics S.A. - Special Call | |
Mar. 13 | Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.96% | 329M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- RVU Stock
- News Ryvu Therapeutics S.A.
- Ryvu Therapeutics S.A. announced that it has received €22 million in funding from European Investment Bank, Investment Arm